# Andreas M. Zeiher

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andreas-m-zeiher/

## Facts

| Field | Value |
| --- | --- |
| Citations | 113,686 |
| Field | Angiogenesis and VEGF in Cancer |
| h-index | 164 |
| i10-index | 517 |
| Last Known Institution | Goethe University Frankfurt |
| OpenAlex ID | https://openalex.org/A5061907666 |
| ORCID iD | https://orcid.org/0000-0003-1711-5819 |
| Works | 1,003 |

## Researcher papers

- [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)
- [Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome](https://scholariq.org/papers/alirocumab-and-cardiovascular-outcomes-after-acute-coronary-syndrome/)
- [ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-4/)
- [Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction](https://scholariq.org/papers/intracoronary-bone-marrow-derived-progenitor-cells-in-acute-myocardial/)
- [European Society of Cardiology: cardiovascular disease statistics 2021](https://scholariq.org/papers/european-society-of-cardiology-cardiovascular-disease-statistics-2021/)
- [European Society of Cardiology: Cardiovascular Disease Statistics 2019](https://scholariq.org/papers/european-society-of-cardiology-cardiovascular-disease-statistics-2019/)
- [Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial](https://scholariq.org/papers/effect-of-alirocumab-a-monoclonal-antibody-to-pcsk9-on-long-term-cardiovascular/)
- [Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial](https://scholariq.org/papers/effects-of-alirocumab-on-cardiovascular-and-metabolic-outcomes-after-acute/)
- [Accuracy of Anthropometric Indicators of Obesity to Predict Cardiovascular Risk](https://scholariq.org/papers/accuracy-of-anthropometric-indicators-of-obesity-to-predict-cardiovascular-risk/)
- [S1-Leitlinie Post-COVID/Long-COVID](https://scholariq.org/papers/s1-leitlinie-post-covid-long-covid/)

## Researcher topics

- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)
- [Cardiac Fibrosis and Remodeling](https://scholariq.org/topics/cardiac-fibrosis-and-remodeling/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Researcher university

- [Goethe University Frankfurt](https://scholariq.org/institutions/goethe-university-frankfurt/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.